An overview of over-the-counter contraceptives: Spotlight on daily oral norgestrel.
Where this comes from
- Record sourced from PubMed, PMID 40897460.
- Also identified by DOI 10.3949/ccjm.92a.24108.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In July 2023, the US Food and Drug Administration approved the first over-the-counter (OTC) daily oral contraceptive pill, Opill (norgestrel). The widespread availability of a daily oral contraceptive pill without a prescription is a major advancement in reproductive health and improves access to safe, effective, affordable contraception. This article outlines the types of OTC contraceptives currently available in the United States, with a focus on OTC norgestrel and its implications for increased accessibility to reproductive healthcare.
Medical subject headings
- Nonprescription Drugs
- Contraceptives, Oral